参考文献

2020-10-19

1: Gerlach M, Kraft T, Brenner B, Petersen B, Niemann H, Montag J. Efficient Knock-in of a Point Mutation in Porcine Fibroblasts Using the CRISPR/Cas9-GMNN Fusion Gene. Genes (Basel). 2018 Jun 13;9(6). pii: E296. doi: 10.3390/genes9060296. PubMed PMID: 29899280; PubMed Central PMCID: PMC6027509.

2: Geerlings MJ, Volokhina EB, de Jong EK, van de Kar N, Pauper M, Hoyng CB, van den Heuvel LP, den Hollander AI. Genotype-phenotype correlations of low-frequency variants in the complement system in renal disease and age-related macular degeneration. Clin Genet. 2018 Jun 11. doi: 10.1111/cge.13392. [Epub ahead of print] PubMed PMID: 29888403.

3: Hu Z, Shi Z, Guo X, Jiang B, Wang G, Luo D, Chen Y, Zhu YS. Ligase IV inhibitor SCR7 enhances gene editing directed by CRISPR-Cas9 and ssODN in human cancer cells. Cell Biosci. 2018 Feb 19;8:12. doi: 10.1186/s13578-018-0200-z. eCollection 2018. PubMed PMID: 29468011; PubMed Central PMCID: PMC5819182.

4: Shao S, Ren C, Liu Z, Bai Y, Chen Z, Wei Z, Wang X, Zhang Z, Xu K. Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing Saccharomyces cerevisiae Rad52. Int J Biochem Cell Biol. 2017 Nov;92:43-52. doi: 10.1016/j.biocel.2017.09.012. Epub 2017 Sep 18. PubMed PMID: 28928041.

5: Li G, Zhang X, Zhong C, Mo J, Quan R, Yang J, Liu D, Li Z, Yang H, Wu Z. Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells. Sci Rep. 2017 Aug 21;7(1):8943. doi: 10.1038/s41598-017-09306-x. PubMed PMID: 28827551; PubMed Central PMCID: PMC5566437.

6: Darwish S, Parang K, Marshall J, Goebel DJ, Tiwari R. Efficient synthesis of CN2097 using in situ activation of sulfhydryl group. Tetrahedron Lett. 2017 Aug 2;58(31):3053-3056. doi: 10.1016/j.tetlet.2017.06.066. Epub 2017 Jun 23. PubMed PMID: 28824209; PubMed Central PMCID: PMC5557301.

7: Lin C, Li H, Hao M, Xiong D, Luo Y, Huang C, Yuan Q, Zhang J, Xia N. Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells. Sci Rep. 2016 Oct 7;6:34531. doi: 10.1038/srep34531. PubMed PMID: 27713537; PubMed Central PMCID: PMC5054376.

8: Gkotzamanidou M, Terpos E, Bamia C, Munshi NC, Dimopoulos MA, Souliotis VL. DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7. Blood. 2016 Sep 1;128(9):1214-25. doi: 10.1182/blood-2016-01-691618. Epub 2016 Jul 21. PubMed PMID: 27443291; PubMed Central PMCID: PMC5524533.

9: Greco GE, Matsumoto Y, Brooks RC, Lu Z, Lieber MR, Tomkinson AE. SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV. DNA Repair (Amst). 2016 Jul;43:18-23. doi: 10.1016/j.dnarep.2016.04.004. Epub 2016 May 7. PubMed PMID: 27235626; PubMed Central PMCID: PMC5042453.

10: Ma Y, Chen W, Zhang X, Yu L, Dong W, Pan S, Gao S, Huang X, Zhang L. Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing in rats by inhibiting NHEJ and using Cas9 protein. RNA Biol. 2016 Jul 2;13(7):605-12. doi: 10.1080/15476286.2016.1185591. Epub 2016 May 10. PubMed PMID: 27163284; PubMed Central PMCID: PMC4962809.

11: Liu M, Wang Y, Wang F, Xia M, Liu Y, Chen Y, Zhao MH. Interaction of uromodulin and complement factor H enhances C3b inactivation. J Cell Mol Med. 2016 Oct;20(10):1821-8. doi: 10.1111/jcmm.12872. Epub 2016 Apr 26. PubMed PMID: 27113631; PubMed Central PMCID: PMC5020621.

12: Wang FM, Song D, Pang Y, Song Y, Yu F, Zhao MH. The dysfunctions of complement factor H in lupus nephritis. Lupus. 2016 Oct;25(12):1328-40. doi: 10.1177/0961203316642307. Epub 2016 Apr 11. PubMed PMID: 27068115.

13: Yang D, Scavuzzo MA, Chmielowiec J, Sharp R, Bajic A, Borowiak M. Enrichment of G2/M cell cycle phase in human pluripotent stem cells enhances HDR-mediated gene repair with customizable endonucleases. Sci Rep. 2016 Feb 18;6:21264. doi: 10.1038/srep21264. PubMed PMID: 26887909; PubMed Central PMCID: PMC4757933.

14: Song J, Yang D, Xu J, Zhu T, Chen YE, Zhang J. RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency. Nat Commun. 2016 Jan 28;7:10548. doi: 10.1038/ncomms10548. PubMed PMID: 26817820; PubMed Central PMCID: PMC4738357.

15: Vartak SV, Raghavan SC. Inhibition of nonhomologous end joining to increase the specificity of CRISPR/Cas9 genome editing. FEBS J. 2015 Nov;282(22):4289-94. doi: 10.1111/febs.13416. Epub 2015 Sep 9. Review. PubMed PMID: 26290158.

16: Chu VT, Weber T, Wefers B, Wurst W, Sander S, Rajewsky K, Kühn R. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol. 2015 May;33(5):543-8. doi: 10.1038/nbt.3198. Epub 2015 Mar 24. PubMed PMID: 25803306.

17: Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol. 2015 May;33(5):538-42. doi: 10.1038/nbt.3190. Epub 2015 Mar 23. Erratum in: Nat Biotechnol. 2016 Feb;34(2):210. PubMed PMID: 25798939; PubMed Central PMCID: PMC4618510.

18: John F, George J, Srivastava M, Hassan PA, Aswal VK, Karki SS, Raghavan SC. Pluronic copolymer encapsulated SCR7 as a potential anticancer agent. Faraday Discuss. 2015;177:155-61. doi: 10.1039/c4fd00176a. PubMed PMID: 25608025.

19: John F, George J, Vartak SV, Srivastava M, Hassan PA, Aswal VK, Karki SS, Raghavan SC. Enhanced efficacy of pluronic copolymer micelle encapsulated SCR7 against cancer cell proliferation. Macromol Biosci. 2015 Apr;15(4):521-34. doi: 10.1002/mabi.201400480. Epub 2014 Dec 16. PubMed PMID: 25515310.

20: Wyatt MK, Tsai JY, Mishra S, Campos M, Jaworski C, Fariss RN, Bernstein SL, Wistow G. Interaction of complement factor h and fibulin3 in age-related macular degeneration. PLoS One. 2013 Jun 28;8(6):e68088. doi: 10.1371/journal.pone.0068088. Print 2013. PubMed PMID: 23840815; PubMed Central PMCID: PMC3696004.